Platelet-rich plasma collection and preparation: a retrospective analysis of 256 cases
Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 10
Abstract
Objective To retrospectively analyze the safety and product quality of NGL XCF 3000 blood cell separator for collecting platelet-rich plasma (PRP) in 256 cases, so as to provide reference for safe collection and product quality control of PRP. Methods The data of 256 patients receiving PRP treatment in our hospital from June 2021 to June 2022 were statistically analyzed, and the differences in the collection time, circulating blood volume and the occurrence of adverse reactions to blood donation were analyzed when NGL XCF 3000 was used to collect autologous PRP among patients of different genders, ages and platelet counts. The differences in platelet content, red blood cell(RBC) contamination and white blood cell(WBC) residues in PRP products were analized. Results 1) There were no significant differences in collection time, circulating blood volume and collection volume among patients of different genders, ages and platelet counts (P<0.05). 2) The contents of WBC, RBC and platelet were not significantly different between male and female patients after collection (P<0.05); 3) The WBC contents increased with the increase of age, and the WBC residue in the elder group[ 56 to78 years old, (0.64±0.41) ×109/L] was significantly higher than that in the younger group[group 1,18 to 40 years old, (0.50±0.35)×109/L], with significant difference was Statistically significant (P<0.05). 4) The residues of WBCs and RBCs in in low platelet group [group 1, (100-150)×109/L] were higher than those in other platelet count groups, and the difference was Statistically significant (P<0.05), and the platelet count in this product was significantly lower than that in other platelet count groups (P<0.05). Conclusion The NGL XCF 3000 blood cell separator is safe and stable for PRP collection in patients with different genders, ages and platelet counts of (100-450)×109/L, and the PRP products collected can meet clinical therapeutic needs.
Authors and Affiliations
Lijuan YANG, Yan HU, Yajuan WU, Li ZHANG, Liping LIU, Tao PENG, Xinyu GAN
Keywords
Related Articles
- EP ID EP738672
- DOI 10.13303/j.cjbt.issn.1004-549x.2023.10.021
- Views 70
- Downloads 0
Application and prospects of homologous allogeneic platelet-rich plasma in wound repair
The application of platelet-rich plasma (PRP) in wound repair is progressively garnering attention. However, certain patients, owing to relative or absolute contraindications, encounter impediments in the acquisition or...
Injection of platelet-rich plasma at the fracture site combined with microfracture surgery for the treatment of delayed fracture healing
[Objective] To report a new technique that combines microfracture surgery under local anesthesia with injection of platelet-rich plasma (PRP) at the fracture site, so as to improve fracture healing rates. [Methods] Data...
Hemolytic disease of newborn caused by unexpected antibodies: a retrospective study of 287 cases
Objective To observe the distribution of non-ABO-HDN and its clinical relevance, so as to provide reference for clinical diagnosis and treatment. Methods A total of 287 cases of non-ABO-HDN recorded during January 2012 t...
Comprehensive factors in adverse reactions to apheresis platelet donation in Lanzhou area
Objective To analyze the comprehensive factors causing adverse reactions to apheresis platelet donation(ARAPD), so as to provide references for effective prevention of ARAPD. Methods The 272 cases of ARAPD from 2012 to 2...
Application of improved comparability verification method in performance verification of instruments and equipment
Objective To explore the viability of improved comparability verification method for the performance verification of automatic biochemical analyzer in blood centers. Methods According to the relevant requirements of User...